Treatment of Drug-Susceptible Tuberculosis.
1 Section of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut.
Charles S
CS
Dela Cruz
2 Section of Pulmonary and Critical Care Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
Patrick G
PG
Lyons
3 Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California.
Susan
S
Pasnick
4 Division of Pulmonary Disease and Critical Care Medicine, Mount Auburn Hospital, Cambridge, Massachusetts.|5 Harvard Medical School, Boston, Massachusetts; and.
Tanya
T
Weinstock
3 Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California.
Payam
P
Nahid
6 Division of Allergy, Pulmonary, Critical Care, and Sleep Medicine, Boston University Medical Center, Boston, Massachusetts.
Kevin C
KC
Wilson
4 Division of Pulmonary Disease and Critical Care Medicine, Mount Auburn Hospital, Cambridge, Massachusetts.|5 Harvard Medical School, Boston, Massachusetts; and.
Carey C
CC
Thomson
D000995:Antitubercular Agents; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D014376:Tuberculosis; D018088:Tuberculosis, Multidrug-Resistant
D000995:Antitubercular Agents